listed · IPO · BSE SME · listed 29 March 2026

SPECIALITY MEDICINES LIMITED

Raised ₹29.14 Cr at ₹124 per share.

+1.5%

listing-day move

Issue price

₹124

Issue size

₹29.14 Cr

Listing-day close

₹125.9

Return since listing

+67.94%

Company research

Source: Tijori Finance · third-party enrichment

About the company

Speciality Medicines, established in 2021, specializes in exporting, trading, and distributing pharmaceutical medicines and vaccines globally, known for quality and reliability.

Financials (₹ crore)

Period	Revenue	PAT	Debt
Mar 2023	23.18 Cr	1.7 Cr	3.64 Cr
Mar 2024	27.52 Cr	2.93 Cr	2.86 Cr
Mar 2025	58.27 Cr	8.61 Cr	5.05 Cr

Revenue mix

Chronic Diseases 47.8%

Vaccines 27.6%

Critical Care 14.9%

Anti-Infectives 6.1%

Specialty Care 3.5%

Others 0.1%

Peer comparison

Company	Mkt cap (Cr)	Revenue	PAT	P/E	P/B
SPML	192	58.27 Cr	8.61 Cr	22.33	—
REMUS	840	620 Cr	29.07 Cr	22.7	—
TLL	297	86.96 Cr	11.75 Cr	15.58	3.67
MONOPHARMA	22	168 Cr	3.09 Cr	7	—

Exchange filings

Fields captured from NSE and BSE

Issue information

Symbol: SML09

Data sources: BSE , MONEYCONTROL . Data quality clean.